Results 31 to 40 of about 314,862 (218)

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

open access: yesMolecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena   +15 more
wiley   +1 more source

Al-Qur’ān dan Reproduksi Perempuan dalam Perspektif Aktivis Gender Indonesia (Analisis Tafsir Nur Rofi’ah)

open access: yesAqwal, 2021
Women naturally experience five biological experiences of women in the form of menstruation, pregnancy, childbirth, postpartum, and breastfeeding. Reproductive function is often found with pain, exhaustion, and risk.
Aisyah Aisyah, Kurdi Fadal
doaj   +1 more source

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

open access: yesMolecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel   +12 more
wiley   +1 more source

Deep learning models will shape the future of stem cell research

open access: yesStem Cell Reports, 2023
Summary: Our ability to understand and control stem cell biology is being augmented by developments on two fronts, our ability to collect more data describing cell state and our capability to comprehend these data using deep learning models.
John F. Ouyang   +2 more
doaj   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Metabolomics: history of development, methods, and current trends in practical medicine

open access: yesActa Biomedica Scientifica
The review reflects the current understanding of metabolomic research, which simultaneously identifies and quantifies thousands of metabolites in a single biological sample.
T. V. Pochtarenko   +6 more
doaj   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

СРАВНИТЕЛЬНЫЙ АНАЛИЗ ПУБЛИКАТОРСКОЙ АКТИВНОСТИ ДОКТОРОВ НАУК МЕДИКО-БИОЛОГИЧЕСКОГО ПРОФИЛЯ Г. НОВОСИБИРСКА1

open access: yesБиблиосфера, 2010
The publishing activity of doctors on medical and biological sciences working in branch and academic sectors of Novosibirsk academic and high school institutions is investigated.

doaj  

Experimental and analytical pipeline for sub-genomic RNA landscape of coronavirus by Nanopore sequencer

open access: yesMicrobiology Spectrum
Coronaviruses (CoVs), including severe acute respiratory syndrome coronavirus 2, can infect a variety of mammalian and avian hosts with significant medical and economic consequences.
Bo-Jia Chen   +4 more
doaj   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy